Fibrinogen alpha chain

From WikiMD's Wellness Encyclopedia

Fibrinogen alpha chain is a protein that plays a crucial role in the blood coagulation process, which is essential for wound healing and stopping bleeding. It is one of the three chains (alpha, beta, and gamma) that make up the fibrinogen molecule, a soluble plasma protein produced by the liver. Fibrinogen is converted by thrombin into fibrin during blood coagulation, forming a fibrin mesh that traps blood cells to form a stable blood clot.

Structure[edit | edit source]

The fibrinogen alpha chain is encoded by the FGA gene in humans. This chain, along with the beta (FGB) and gamma (FGG) chains, forms the hexameric fibrinogen molecule through disulfide bonds. Each fibrinogen molecule is composed of two sets of these three chains, resulting in the structure (αβγ)_2. The alpha chain plays a significant role in the polymerization of fibrinogen into fibrin and in the cross-linking that provides the clot with stability.

Function[edit | edit source]

The primary function of the fibrinogen alpha chain is in the formation of the fibrin clot. Upon activation by thrombin, fibrinogen undergoes a conformational change that exposes binding sites for other fibrinogen molecules, leading to the formation of a fibrin network. The alpha chain contains specific sites that are involved in the cross-linking of fibrin strands by the enzyme factor XIII, further stabilizing the clot.

Clinical Significance[edit | edit source]

Alterations in the fibrinogen alpha chain can lead to various bleeding disorders. Congenital fibrinogen deficiencies, such as afibrinogenemia (complete lack of fibrinogen), hypofibrinogenemia (low levels of fibrinogen), and dysfibrinogenemia (functionally defective fibrinogen), are rare but can lead to significant bleeding complications or thrombotic events. These conditions can be diagnosed through blood tests that measure fibrinogen levels and function.

Genetics[edit | edit source]

The FGA gene is located on chromosome 4q31.3 and contains 10 exons. Mutations in the FGA gene can result in the aforementioned fibrinogen disorders. Genetic testing can identify mutations in individuals with suspected fibrinogen deficiencies or dysfunctions.

Treatment[edit | edit source]

Treatment for disorders related to the fibrinogen alpha chain depends on the severity and nature of the condition. For individuals with bleeding symptoms, treatment may include fibrinogen concentrate infusions to restore normal levels. In cases of dysfibrinogenemia with thrombotic risk, anticoagulant therapy may be considered.


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD